Palatin Technologies
PTN
#10723
Rank
$13.7 M
Marketcap
$7.70
Share price
-1.41%
Change (1 day)
N/A
Change (1 year)

Palatin Technologies (PTN) - Net assets

Net assets on the balance sheet as of March 2026 : $10.59 Million USD

According to Palatin Technologies's latest financial reports the company has $10.59 Million USD in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Palatin Technologies - Net assets on balance sheet (from 2001 to 2026)

Net assets by year

Year Net assets Change
2025-06-30$-$4.78 Million4184.46%
2024-06-30$-$0.12 Million-94.37%
2023-06-30$-$1.98 Million-112.17%
2022-06-30$$16.26 M-67.24%
2021-06-30$$49.65 M-38.07%
2020-06-30$$80.17 M-20.27%
2019-06-30$$0.10 B272.89%
2018-06-30$$26.96 M-622.11%
2017-06-30$-$5.17 Million-70.63%
2016-06-30$-$17.59 Million-244.09%
2015-06-30$$12.2 M24.68%
2014-06-30$$9.78 M-57.4%
2013-06-30$$22.97 M1155.03%
2012-06-30$$1.83 M-89.94%
2011-06-30$$18.19 M95.23%
2010-06-30$$9.31 M181.22%
2009-06-30$$3.31 M-49.43%
2008-06-30$$6.55 M-64.64%
2007-06-30$$18.53 M1.27%
2006-06-30$$18.29 M98.37%
2005-06-30$$9.22 M-52.41%
2004-06-30$$19.38 M3.91%
2003-06-30$$18.65 M114.77%
2002-06-30$$8.68 M-27.1%
2001-06-30$$11.91 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Johnson & Johnson
JNJ
$81.18 B 766,391.38%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
$47.38 B 447,260.72%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
$3.40 B 32,069.87%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
$39.4 M 272.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
$0.99 B 9,315.89%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
$0.56 B 5,208.77%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
$3.37 M-68.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
$0.14 B 1,303.17%๐Ÿ‡บ๐Ÿ‡ธ USA